NO158060C - Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonforbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonforbindelser.

Info

Publication number
NO158060C
NO158060C NO831056A NO831056A NO158060C NO 158060 C NO158060 C NO 158060C NO 831056 A NO831056 A NO 831056A NO 831056 A NO831056 A NO 831056A NO 158060 C NO158060 C NO 158060C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
quinolone compounds
analogy procedure
active quinolone
Prior art date
Application number
NO831056A
Other languages
English (en)
Norwegian (no)
Other versions
NO158060B (no
NO831056L (no
Inventor
Mark Philip Wentland
Denis Mahlon Bailey
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NO831056L publication Critical patent/NO831056L/no
Priority to NO871324A priority Critical patent/NO167915C/no
Publication of NO158060B publication Critical patent/NO158060B/no
Publication of NO158060C publication Critical patent/NO158060C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO831056A 1982-03-31 1983-03-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonforbindelser. NO158060C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO871324A NO167915C (no) 1982-03-31 1987-03-30 Nye kinolonmellomprodukter

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36387682A 1982-03-31 1982-03-31
US06/466,095 US4499091A (en) 1982-03-31 1983-02-14 1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents

Publications (3)

Publication Number Publication Date
NO831056L NO831056L (no) 1983-10-03
NO158060B NO158060B (no) 1988-03-28
NO158060C true NO158060C (no) 1988-07-06

Family

ID=27002249

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831056A NO158060C (no) 1982-03-31 1983-03-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonforbindelser.

Country Status (14)

Country Link
US (1) US4499091A (fi)
KR (1) KR880002353B1 (fi)
AU (1) AU557534B2 (fi)
CA (1) CA1198425A (fi)
DK (1) DK162638C (fi)
ES (1) ES521153A0 (fi)
FI (1) FI77855C (fi)
GR (1) GR77906B (fi)
IE (1) IE54898B1 (fi)
IL (1) IL68236A (fi)
NO (1) NO158060C (fi)
NZ (1) NZ203621A (fi)
PH (1) PH18392A (fi)
PT (1) PT76456B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
DE3409922A1 (de) * 1984-03-17 1985-09-26 Bayer Ag, 5090 Leverkusen 1,7-diamino-1,4-dihydro-4-oxo-3-(aza)chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung bakterieller erkrankungen
FR2574404B1 (fr) * 1984-12-12 1987-04-24 Provesan Sa Derives 1-substitues de l'acide 6-fluoro-7-(pyrrol-1-yl)-1,4-dihydro-4-oxoquinoleine-3-carboxylique, leur preparation et leur application en tant que medicaments
US4578473A (en) * 1985-04-15 1986-03-25 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
IN166416B (fi) * 1985-09-18 1990-05-05 Pfizer
US4692454A (en) * 1986-02-03 1987-09-08 Warner-Lambert Company Opthalmic use of quinolone antibiotics
DE3606698A1 (de) * 1986-03-01 1987-09-03 Bayer Ag 7-(1-pyrrolidinyl)-chinoloncarbonsaeure -derivate
US5153204A (en) * 1986-03-01 1992-10-06 Bayer Aktiengesellschaft 7-(1-Pyrrolidinyl)-quinolonecarboxylic acid derivatives
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
IL83049A (en) * 1986-07-04 1991-12-12 Chemie Linz Ag 4-quinolinone-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
EP0259804B1 (de) * 1986-09-12 1993-11-18 F. Hoffmann-La Roche Ag Pyrido [3,2,1-ij]-1,3,4-benzoxadiazinderivate, Verfahren zu deren Herstellung, entsprechende pharmazeutische Präparate und im Verfahren verwendbare Zwischenprodukte
US4929613A (en) * 1987-08-26 1990-05-29 Warner-Lambert Company Antibacterial agents
US4868305A (en) * 1988-02-16 1989-09-19 Sterling Drug Inc. Improvement in the preparation of intermediates for quinoline antibacterial agents
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
JP2003527308A (ja) 1998-12-04 2003-09-16 インフラックス,インコーポレイテッド 多剤輸送体の阻害剤
US6262072B1 (en) 1999-10-12 2001-07-17 Yung Shin Pharmaceutical Industrial Co. Ltd. Orally administered antimicrobial pharmaceutical formulations of ciprofloxacin
US6957105B2 (en) * 2002-03-26 2005-10-18 Cardiac Pacemakers, Inc. Method and apparatus for detecting oscillations in cardiac rhythm with electrogram signals
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
CA1175836A (en) * 1977-09-20 1984-10-09 Marcel Pesson Production of 1,4-dihydroquinoline-3-carboxylic acid derivatives
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten

Also Published As

Publication number Publication date
KR840004102A (ko) 1984-10-06
IE54898B1 (en) 1990-03-14
PT76456B (en) 1985-12-10
AU1272283A (en) 1983-10-06
KR880002353B1 (ko) 1988-10-29
DK145983D0 (da) 1983-03-30
AU557534B2 (en) 1986-12-24
FI77855C (fi) 1989-05-10
ES8405390A1 (es) 1984-06-01
CA1198425A (en) 1985-12-24
IE830608L (en) 1983-09-30
GR77906B (fi) 1984-09-25
IL68236A (en) 1986-09-30
PH18392A (en) 1985-06-21
DK162638B (da) 1991-11-25
FI77855B (fi) 1989-01-31
FI831102L (fi) 1983-10-01
US4499091A (en) 1985-02-12
PT76456A (en) 1983-04-01
NO158060B (no) 1988-03-28
DK162638C (da) 1992-04-21
NZ203621A (en) 1986-01-24
IL68236A0 (en) 1983-06-15
DK145983A (da) 1983-10-01
FI831102A0 (fi) 1983-03-30
ES521153A0 (es) 1984-06-01
NO831056L (no) 1983-10-03

Similar Documents

Publication Publication Date Title
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO160368C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske azoforbindelser.
NO161372C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive guaninderivater.
NO164835C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO158060C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonforbindelser.
NO159446C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO155133C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme dicykliske forbindelser.
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO156865B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO158376C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme rooperolforbindelser.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO163529C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte azabicykloalkaner.
NO155539C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater.
NO157934C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider.
NO159798C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporin-oksyder.
NO157736C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.